Buddhadev “Buddha” Chaudhuri, PhD, is CEO and Co-Founder of Keylika. With over 15 years of R&D experience, Dr Chaudhuri is a subject-matter expert in drug delivery microtechnologies. He holds a PhD in transdermal drug delivery microsystems from Imec/KU Leuven, Belgium, and was a Post-Doctoral Fellow at the University of California, San Francisco (UCSF) and UC Berkeley. Dr Chaudhuri has successfully led the technology development at several medtech start-ups in Europe and the US. The most notable amongst them is Biolinq, where he spearheaded the microneedle technology development for dermal sensing of glucose.